Assesment of a Predictive Model Dosage of EPO in Hemodialysis Patients

Post-authorization Safety Study in CKD Subjects Receiving HX575 i.v.

NCT00632125 ·Status: COMPLETED ·Phase: PHASE4

Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Hemodialysis Patients

NCT00233597 ·Status: COMPLETED ·Phase: PHASE3

Erythropoietin (EPO) to Protect Renal Function After Cardiac Surgery

NCT01423955 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Safety and Efficacy of GSK1278863 in Non-Dialysis Dependent (NDD) Subjects With Anemia Associated With Chronic Kidney Diseases (CKD)

NCT01977573 ·Status: COMPLETED ·Phase: PHASE2

Erythropoietin Therapy in Patients With Chronic Renal Failure: A Study of Time Dependent Activity

NCT00744445 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of Dose Response Relationship, Safety and Efficacy of GSK1278863 in Hemodialysis-dependent Subjects With Chronic Kidney Disease Associated Anemia

NCT01977482 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of Two Epoetin Alfa Dosing Strategies in Subjects With Chronic Kidney Disease Receiving Hemodialysis

NCT02253654 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate the Efficacy and Safety of HX575 Hexal AG vs ERYPO® for the Treatment of Anemia in Hemodialysis Patients

NCT00666835 ·Status: COMPLETED ·Phase: PHASE3

4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease

NCT01587924 ·Status: COMPLETED ·Phase: PHASE2

Study of Erythropoietin (EPO) Administration Schedule

NCT01111630 ·Status: COMPLETED ·Phase: PHASE4

Prospective Observational Study of Erythropoietin-Iron Interaction in Anemia of Renal Disease

NCT01719146 ·Status: COMPLETED

Randomized, Controlled, Double-blind Multicenter Safety Study to Evaluate the Safety and Immunogenicity of Subcutaneous EPO HEXAL vs. ERYPO® in the Treatment of Anemia Associated With Chronic Renal Insufficiency in Predialysis Patients

NCT00701714 ·Status: TERMINATED ·Phase: PHASE3

A Non-interventional, Epidemiological, Registry-based Evaluation of Anaemia in Swedish Patients With Chronic Kidney Disease

NCT03643601 ·Status: COMPLETED

Therapeutic Education of Chronic Renal or Renal Transplant Patient in the Management of EPO Injections

NCT03481686 ·Status: COMPLETED ·Phase: NA

Safety & Efficacy of EPO-018B for the Treatment of Anemia in Participants With Chronic Kidney Diseases Not on Dialysis

NCT02403362 ·Status: UNKNOWN ·Phase: PHASE2

" Evaluation of Erythropoietin Therapy in Patients With End-Stage Kidney Disease on Regular Hemodialysis: Hemoglobin Outcomes, and Metabolic Syndrome as a Risk Factor for Erythropoietin Resistance "

NCT06983756 ·Status: NOT_YET_RECRUITING

Effectiveness of a Biosimilar Epoetin Alfa in Stable 'End Stage Renal Failure'

NCT02341547 ·Status: UNKNOWN

Switch From Oral Iron to Intravenous Ferric Carboxymaltose in Non-dialysis Chronic Kidney Disease (CKD)

NCT02232906 ·Status: COMPLETED ·Phase: PHASE4

Treatment Response in Dialysis Anaemia

NCT02707757 ·Status: COMPLETED ·Phase: PHASE4

Study of the Relationship Between rHuEPO Dose, Serum ADPN, and Mortality in Patients Beginning HD

NCT00457535 ·Status: TERMINATED

A Study of NeoRecormon (Epoetin Beta) in Patients With Renal Anemia.

NCT00440063 ·Status: TERMINATED ·Phase: PHASE4

A Study to Evaluate Whether Correction of Anemia Using Recombinant Human Erythropoietin Reduces the Progression of Atherosclerosis and Cardiac Hypertrophy in Pre-dialysis Chronic Kidney Disease Patients

NCT00563355 ·Status: COMPLETED ·Phase: NA

Phase III Study of GSK1278863 in Japanese Non-dialysis (ND) and Peritoneal Dialysis (PD) Subjects With Renal Anemia

NCT02791763 ·Status: COMPLETED ·Phase: PHASE3

EPO-BUL-01 - Study of the Optimization of Anemia Management of EPREX (Epoetin Alfa) in Predialysis Patients With Chronic Renal Failure

NCT00338000 ·Status: COMPLETED ·Phase: PHASE4

Correction of Anaemia and Progression of Renal Failure on Transplanted Patients

NCT00396435 ·Status: COMPLETED ·Phase: PHASE4